Assessing the comparative effectiveness of tocilizumab in giant cell arteritis within a de novo health economic model, based on the giacta trial and data from market scan database

Category Primary study
JournalValue in Health
Year 2017
This article has no abstract
Epistemonikos ID: dbf49e20600ce59ae6495b27e4acfd4d5e4bb52a
First added on: Feb 08, 2025